ALFA FinderBSE filing, BSE: 544629. Summary written from the filing by ALFA Finder's alert engine.
Ravelcare Ltd: key numbers
- Share price
- ₹98.00
- Market cap
- ₹67.22 Cr
- Revenue (annual)
- ₹26.95 Cr
- Net profit (annual)
- ₹5.15 Cr
- P/E (TTM)
- 13.0×Sector 40.7×
- Promoter holding
- 72.94%
- FII holding
- 1.82%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Ravelcare Ltd
All →Ravelcare Investor Presentation: Key Takeaways
H1 FY27 revenue ₹15.15 Cr (+20.7% vs H2 FY26), PAT ₹3.84 Cr (+96.6% vs H2, +19.8% vs H1 FY26), EBITDA margin 29.6%. Debt-free with ₹26.6 Cr cash; PRO range live, skincare due December 2026.
Ravelcare Other Announcement
Ravelcare reported no deviation in IPO fund use for the half year ended 30 September 2026. Rs.1,328.60 lakh of Rs.2,410.20 lakh proceeds were utilised.
Ravelcare H1 FY27 Results: Net Profit ₹3.8 Cr, Up 18.7% YoY
Ravelcare Limited's board approved unaudited standalone results for the half year ended September 2026. The results carry a limited review report from statutory auditors.
- Key figure
- Net profit ₹3.8 Cr · +18.7% YoY
Ravelcare Board Meeting Date
Ravelcare will meet on November 12, 2026 to consider unaudited half-year results. The trading window stays closed until 48 hours after the results declaration.
Ravelcare Other Announcement
Ravelcare Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulations. This is a routine compliance disclosure.
Ravelcare Annual General Meeting
Ravelcare Ltd submitted the proceedings of its 8th AGM held on September 23, 2026. Items covered adoption of audited FY26 financials and re-appointment of the MD, WTD, and a retiring director.
Other results update announcements
All →Jubilant Pharmova Results Update
Q2 revenue rose 21% to Rs 2,370 Cr, but EBITDA fell 27% and PAT dropped to Rs 31 Cr. SPECT supply gaps and remediation costs compressed margins.
Frog Innovations Results Update
Frog Innovations reported H1 FY27 revenue up 17.4% to Rs. 645.0 Mn, with profit after tax of Rs. 8.7 Mn. Results highlight a turnaround in profitability.
TVS Supply Chain Solutions Results Update
TVS Supply Chain Solutions reported Q2 FY27 revenue up 38% to ₹3,687.2 Cr. PAT rose 124% to ₹36.5 Cr and EBITDA rose 50%.
Vipul Organics Results Update
Vipul Organics reported Q2 standalone revenue up 56.12% YoY and PAT up 22.20%. Half-year revenue rose 47.51%, though a temporary Sayakha ramp-up weighed on margins.
Phoenix Overseas Results Update
Phoenix Overseas reported H1 revenue of Rs. 35,482 lakh, up about 48%. It returned to profit with PAT of Rs. 168 lakh against a prior-year loss.
Jaykay Enterprises Results Update
Jaykay Enterprises issued an investor release on Q2 and H1 FY2026-27 results, citing income growth. Highlights include defence orders, medical implant approvals and AI platform progress.